DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
— - 2 LOY - 2 Celine Halioua - 2 Daniel Promislow - 1 Ellen Ratcliff - 1 Ratcliff - 1 it's - 1 Halioua - 1
Top related locs:
Pennsylvania mealtimes LOY
Top related orgs:
Service - 2 Business - 2 FDA - 2 US Food and Drug Administration - 1 Dogs - 1 Halioua - 1

Search resuls for: "Halioua"


2 mentions found


☆ The first anti-aging pill for dogs is entering trials — and an 11-year-old whippet named Boo is the first to try it
  + stars: | 2024-02-01 | by ( Hilary Brueck | ) www.businessinsider.com   time to read: +4 min
If they work, they'll make aging dogs feel and act healthier, younger, and more vibrant. Boo, an 11-year-old whippet dog from Pennsylvania, is the very first participant in this clinical trial, from the veterinary medicine startup Loyal. The new STAY study is one of the largest, most diverse dog aging studies of its kind — with plans to enroll more than 1,000 aging dogs across 50 different US sites. Advertisement"A clinical trial doesn't mean the drug works — it means we're going to test whether it works," aging expert Daniel Promislow, who directs the Dog Aging Project , another large study of aging dogs, told Business Insider. (Promislow is not involved with Loyal's drug development.)
Persons: —, LOY, Daniel Promislow, Ellen Ratcliff, Celine Halioua, Ratcliff, it's Organizations: Service, Business, FDA Locations: Pennsylvania, mealtimes, LOY
☆ An anti-aging drug for dogs promises to win owners more time with old pets. It could be FDA-approved soon.
  + stars: | 2023-11-28 | by ( Hilary Brueck | ) www.businessinsider.com   time to read: +2 min
Loyal for Dogs is developing drugs to extend doggie lifespans. One drug just cleared a key FDA hurdle, a sign the agency is ready to take longevity seriously. AdvertisementAn anti-aging drug for dogs is one step closer to doctor's offices, after it cleared a key regulatory hurdle with the US Food and Drug Administration (FDA) earlier this month. On Tuesday, Loyal for Dogs announced that its first-of-its-kind longevity drug received the first of three green lights needed for FDA approval. This is the first time that US regulators have hinted that they could be ready to endorse longevity drugs.
Persons: —, LOY, Celine Halioua, Halioua Organizations: FDA, Service, US Food and Drug Administration, Dogs, Business, Halioua
0 next >>
Total: 2